Virtual poster discussion session 1

28 April 2021

  • days
  • Hours
  • Minutes

PVRI Members

Sign in and register

Non members

Choose an option below.

Academic Industry & roundtable

Chair and moderators

Tim Lahm, Indiana University Medical Center, USA

Brian Graham, University of California, San Francisco, USA

Evangelos Michelakis, University of Alberta, Canada

Christophe Guignabert, Université Paris-Saclay, France

Anton Vonk Noordegraaf, Amsterdam University Medical Center, The Netherlands

Khodr Tello, Justus-Liebig University Giessen, Germany

Agenda

  • Iona Cuthbertson // Therapeutically targeting endothelial cell metabolic dysfunction in pulmonary arterial hypertension with apigenin
  • Prakash Chelladurai // Epigenome-wide profiling uncovers novel gene regulatory networks in human pulmonary arterial hypertension
  • Charifa Awada // Implication of the histone methyltransferase “g9a” in pulmonary arterial hypertension
  • Barbora Kaftanová // Perinatal exposure to serotonin re-uptake inhibitor causes mild pulmonary hypertension in adult female rats
  • Anandharajan Rathinasabapath // Endothelial overexpression of sirt3 protects the metabolic etiology in PAH
  • Tatyana Novoyatleva // Axl is a novel modulator of bone morphogenetic protein receptor 2 in pulmonary arterial hypertension
  • Katherine Kearney Graham // Equivalent outcomes for hereditary and idiopathic pulmonary arterial hypertension in children; an analysis from a national Australian registry
  • Richard Channick // Effect of macitentan across prognostic age groups in patients with pulmonary arterial hypertension (PAH)
  • Pietro Nardelli // Validation of artificial intelligence artery-vein Classification for Contrast CT imaging in PH subjects
  • Victor Tapson // Efficacy in patient subgroups in the INCREASE Trial, a phase III Trial to evaluate inhaled Treprostinil in patients with pulmonary hypertension due to parenchymal Lung Disease
  • Erik Swenson // Acetazolamide and high altitude pulmonary edema prevention
  • Manjula Miglani // Telomeric Tankyrases: a novel and propitious target to ameliorate the maladaptation phenomena at heights

Congratulations to Prakash Chelladurai, who has been awarded the Butrous Young Investigator Award 2020 for his abstract entitled: ‘epigenome-wide profiling uncovers novel gene regulatory networks in human pulmonary arterial hypertension .’

A deeper look

ROUND ONE BASIC:

Poster 1: Therapeutically targeting endothelial cell metabolic dysfunction in pulmonary arterial hypertension with apigenin

15:00-15:05 BST

Presenter: // Iona Cuthbertson, Department of Medicine, University of Cambridge, UK

 

Poster 2: Epigenome-wide profiling uncovers novel gene regulatory networks in human pulmonary arterial hypertension

15:10-15:15 BST

Presenter: // Prakash Chelladurai, Max-Planck-Institute for Heart And Lung Research, Germany

 

Poster 3: Implication of the histone methyltransferase “g9a” in pulmonary arterial hypertension

15:20-15:25 BST

Presenter: // Charifa Awada, the University Institute of Cardiology and Pulmonology of Quebec, Canada

 

Poster 4: Perinatal exposure to serotonin re-uptake inhibitor causes mild pulmonary hypertension in adult female rats

15:30-15:35 BST

Presenter: // Barbora Kaftanová, Department of Physiology, Charles University Second Medical School, Czech Republic

 

Poster 5: Endothelial overexpression of sirt3 protects the metabolic etiology in PAH

15:40-15:45 BST

Presenter: // Anandharajan Rathinasabapathy, Vanderbilt University Medical Centre, USA

 

Poster 6: Axl is a novel modulator of bone morphogenetic protein receptor 2 in pulmonary arterial hypertension

15:50-15:55 BST

Presenter: // Tatyana Novoyatleva, Justus-Liebig-University Giessen, Germany

 

ROUND TWO CLINICAL:

Poster 1: Equivalent outcomes for hereditary and idiopathic pulmonary arterial hypertension in children; an analysis from a national Australian registry

16:00-16:05 BST

Presenter: // Katherine Kearney Graham, University of New South Wales, Australia

 

Poster 2: Effect of macitentan across prognostic age groups in patients with pulmonary arterial hypertension (PAH)

16:10-16:15 BST

Presenter: // Richard Channick, University of California Los Angeles Medical Centre, USA

 

Poster 3: Validation of artificial intelligence artery-vein Classification for Contrast CT imaging in PH subjects

16:20-16:25 BST

Presenter: // Pietro Nardelli, Brigham and Women's Hospital, Harvard Medical School, USA

 

Poster 4: Poster 4: Efficacy in patient subgroups in the INCREASE Trial, a phase III Trial to evaluate inhaled Treprostinil in patients with pulmonary hypertension due to parenchymal Lung Disease

16:30-16:35 BST

Presenter: // Victor Tapson, Cedars-Sinai Medical Centre, USA

 

Poster 5: Acetazolamide and high altitude pulmonary edema prevention

16:40-16:45 BST

Presenter: // Erik Swenson University of Washington, USA

 

Poster 6: Telomeric Tankyrases: A novel and propitious target to ameliorate the maladaptation phenomena at heights

16:50-16:55 BST

Presenter: // Manjula Miglani, SRM University, Haryana, India

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg